These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23279181)

  • 41. Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls.
    Cousijn J; Vingerhoets WA; Koenders L; de Haan L; van den Brink W; Wiers RW; Goudriaan AE
    Addict Biol; 2014 Mar; 19(2):282-93. PubMed ID: 24589297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies.
    Rapp C; Bugra H; Riecher-Rössler A; Tamagni C; Borgwardt S
    Curr Pharm Des; 2012; 18(32):5070-80. PubMed ID: 22716152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders.
    Kumra S; Robinson P; Tambyraja R; Jensen D; Schimunek C; Houri A; Reis T; Lim K
    J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):171-80. PubMed ID: 22265363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compounded brain volume deficits in schizophrenia-alcoholism comorbidity.
    Mathalon DH; Pfefferbaum A; Lim KO; Rosenbloom MJ; Sullivan EV
    Arch Gen Psychiatry; 2003 Mar; 60(3):245-52. PubMed ID: 12622657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comorbid schizophrenia and substance abuse.
    Green AI; Brown ES
    J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Brain imaging of first-episode psychosis].
    Jardri R
    Encephale; 2013 Sep; 39 Suppl 2():S93-8. PubMed ID: 24084428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopaminergic mechanisms in idiopathic and drug-induced psychoses.
    Lieberman JA; Kinon BJ; Loebel AD
    Schizophr Bull; 1990; 16(1):97-110. PubMed ID: 2185538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
    Mueser KT; Yarnold PR; Levinson DF; Singh H; Bellack AS; Kee K; Morrison RL; Yadalam KG
    Schizophr Bull; 1990; 16(1):31-56. PubMed ID: 2333480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review.
    James A; James C; Thwaites T
    Psychiatry Res; 2013 Dec; 214(3):181-9. PubMed ID: 24139960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sleep Management Among Patients with Substance Use Disorders.
    Chakravorty S; Vandrey RG; He S; Stein MD
    Med Clin North Am; 2018 Jul; 102(4):733-743. PubMed ID: 29933826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of substance abuse on the course and outcome of schizophrenia.
    Turner WM; Tsuang MT
    Schizophr Bull; 1990; 16(1):87-95. PubMed ID: 2185537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice.
    Schneier FR; Siris SG
    J Nerv Ment Dis; 1987 Nov; 175(11):641-52. PubMed ID: 3316490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Schizophrenia, substance use, and brain morphology.
    Scheller-Gilkey G; Lewine RR; Caudle J; Brown FW
    Schizophr Res; 1999 Jan; 35(2):113-20. PubMed ID: 9988848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is it me? Verbal self-monitoring neural network and clinical insight in schizophrenia.
    Sapara A; Ffytche DH; Cooke MA; Williams SC; Kumari V
    Psychiatry Res; 2015 Dec; 234(3):328-35. PubMed ID: 26549744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
    Soyka M
    Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.
    Ramaekers JG; van Wel JH; Spronk D; Franke B; Kenis G; Toennes SW; Kuypers KP; Theunissen EL; Stiers P; Verkes RJ
    Brain Imaging Behav; 2016 Dec; 10(4):1254-1263. PubMed ID: 26667034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.